GlassScriptPhysician profile
India Bane
NPI 1538622915
$2,602.34
in general payments reported to CMS, 2019-2025
17 companies · $958 in 2025
The $958 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $428 · 2022: $637 · 2023: $356 · 2024: $223 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,537.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $503.21 | 2022-2025 | Myrisk, Precisetumor |
| Boston Scientific Corporation | $464.32 | 2025 | Ams 800 Artificial Urinary Sphincter, Ams 700 |
| Astrazeneca Pharmaceuticals LP | $241.41 | 2021-2023 | Fasenra |
| Novocure INC. | $216.42 | 2021 | |
| Sientra, INC. | $205.33 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $166.11 | 2025 | Bard Urinary Drainage Bag |
| Becton, Dickinson and Company | $161.74 | 2024 | Bard Urinary Drainage Bag |
| Janssen Biotech, INC. | $145.98 | 2023-2025 | Erleada |
| Seagen INC. | $125.00 | 2022 | |
| Glaxosmithkline, LLC. | $95.14 | 2021 | |
| Urogen Pharma, INC. | $87.78 | 2023-2025 | Jelmyto |
| Novartis Pharmaceuticals Corporation | $72.42 | 2024-2025 | |
| Tolmar, INC. | $34.52 | 2023-2025 | Eligard, Jatenzo |
| Merck Sharp & Dohme LLC | $28.67 | 2025 | Welireg, Keytruda |
| Verity Pharmaceuticals INC. | $19.98 | 2025 | Tlando |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.30 | 2025 | |
| Accord Healthcare, INC. | $17.01 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw India Bane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.